Physiomics Share Discussion Threads

[pwhite73] 23/5/2018 07:17

owenga23 - "And will probably be back to 5p by the end of the day..."

It may even end up unchanged. The point being is that when you get certain idiots here talking about a 50p - 100p share price and making comparisons to biotechs worth hundreds of millions this 4p placing gives them a good kick up the backside and puts things into perspective.

[no24rton] 23/5/2018 07:13

guys Read the RNS again : he Company has had significant interest from potential new clients. In order to service this level of actual and potential new business the Company is raising funds through the Placing to enable it to carry out associated activities including investing in expanding its in-house team, improving its marketing reach, match funding for future grant projects, and updating its IT infrastructure as well as for general working capital purposes.

[113mike] 23/5/2018 07:10

maybe even 4p?

[owenga] 23/5/2018 07:08

And will probably be back to 5p by the end of the day...

[pwhite73] 23/5/2018 07:06

Its the same nonsense every year. I said 2p I got the first tranche wrong. When the stock drops to 4p and below the next placing later this year will definitely be 2p. With the £500k from Merck, the funding grants and all the other potential global partners they still have to dilute Joe Mug PI and issue 33% discounted shares.

[the stigologist] 23/5/2018 01:40

Consolidating nicely at 6p (the new 1p) with lots of big news catalysts upcoming and possibly imminent.

I suspect PYC in for at least two more grant funding rounds.

We've also yet to hear from the Large Service Provider partnership talks.

Very opportunity and news rich environment this stock and supported now by rising underlying Moving Averages on the chart.

[costax1654x] 22/5/2018 19:52

Guys have a look at Aeg as well.Last RNS was amazing.Potential multibag in 2018.Take care

[spacedust] 22/5/2018 19:17

I think costs are 90% covered. Not 60%

[margic] 22/5/2018 16:30

Once again, your crystal company sea alone will cover circa 60% of this years operating costs. Add the others together is say we are well on our way to profit this fiscal year on current form. Just got to add the number bro!

[billthebank] 22/5/2018 15:25

Next to no revenues? Did you watch the Pro Active interview? Do you not rate their technology? Do you not think Jim Millen will bring it home? Do you not think that they will receive repeat business next year. Do you not rate the fact they have two major Pharma clients including Merck? Do you not think this company has done really well since last Autumn. Well ok Lets see how it pans out then shall we?

[davevt] 22/5/2018 10:07

They can't go much further backwards can they. They need to grow, though I don't know where you see an opportunity? The fact they do next to no revenues and make a loss is because all their competitors took that opportunity away from them.

[margic] 21/5/2018 23:25

So you do see the growth opportunity ;)

[davevt] 21/5/2018 20:13

Coldspring, seems you still struggle to read. All the big boys out there, do exactly what pyc do, and better, and more. That's why they do tens of millions in revenue, have hundreds of customers, bought out for tens to nearly hundreds of millions. Have more data, from more pharmas. Pyc are an aim company, with about 5 customers, and have revenues less than your local pub. Pyc don't 'specialize', they are just behind everyone else.

[coldspring] 21/5/2018 18:41

All of your rhetoric in bad mouthing the prospects of this company stem from it being "small and only specialising in one thing" You suggest one company should be able to deal with all diagnostic requirements? So let's take your argument a stage further....if one size fits all then why are there specialist departments in every hospital in the world, we only need one big department according to you.

[margic] 21/5/2018 18:11

You talk about AI as though it has human capabilities only! LolThe day AI can do plumbing, it will also be able to do Heating, gas, electric, plastering, tiling and so one. There be a program that can be adapted or made to suit and so the story goes!O-Davo O-Davo!

[davevt] 21/5/2018 16:41

Coldspring, you obviously failed to understand my point. If you were going to employ a Bio simulation company for diseases, would you use one that designs Bio markers, designs drugs, and dosage for many many diseases, or go to one that can only model dosage for one disease?

[the stigologist] 21/5/2018 16:02

WALL OF MONEY

Sam Gyimah MP
‏
Verified account

@SamGyimah
2h2 hours ago
More
Big day for UK Science:
- PM outlined commitment post-Brexit to welcoming the brightest & best researchers to the UK
- Association with EU Framework prgms
- Long-term funding target for science & innovation (2.4% of GDP by 2027 = extra £80bn over a decade) #IndustrialStrategy

[the stigologist] 21/5/2018 15:13

This is HUGE ! because it confirms PYC are not just in the B2B market competing with

Certara $850m
Simulations Plus $300m

but also the potentially huge Consumer/B2C market where you are with serious big boys like

Google (Deepmind who Google paid $500m for)

Jeff Bezos/Bill Gates + Big Pharma funded $1 billion+ GRAIL Inc

[billthebank] 21/5/2018 14:57

So Dave totally unconnected huh? Merck contract not worth owt? There is no doubt in my mind that PYC will have a good year in 2018. Time will tell.

[the stigologist] 21/5/2018 14:55

WE KNOW FOR A FACT

Physiomics are working with the Government Funding Body InnovateUK in this EXACT area!!!

There is a WALL of MONEY coming from the Government

When this GUSHER blows, Physiomics are going to get a decent share of this Gold Rush

And Physiomics aren't the suckers looking for the gold they are the ones who will be selling the picks and shovels

This will be MEGA

[the stigologist] 21/5/2018 14:53

Standby...

RNSes incoming over next few days/weeks IMO

[the stigologist] 21/5/2018 14:53

PYC have tweeted the NEWS !!!

[margic] 21/5/2018 14:30

If PYC rns relating to this then the best reaction will be the delayed one. Can't be denied right PYC is very under the radar, almost completely. Wait till it's at the forefront of market attention. Sp could be many multiples of today's price by that time, then it will really be lift off!